DiaMedica Therapeutics Inc (DMAC)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.18
+0.01
(+0.32%)
After-Hours: 20:00
DiaMedica Therapeutics 1 Year Total Returns (Daily): 81.14% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 81.14% |
May 16, 2024 | 78.71% |
May 15, 2024 | 51.41% |
May 14, 2024 | 86.42% |
May 13, 2024 | 96.91% |
May 10, 2024 | 90.49% |
May 09, 2024 | 99.39% |
May 08, 2024 | 101.7% |
May 07, 2024 | 120.5% |
May 06, 2024 | 110.8% |
May 03, 2024 | 78.57% |
May 02, 2024 | 62.35% |
May 01, 2024 | 56.97% |
April 30, 2024 | 55.21% |
April 29, 2024 | 58.90% |
April 26, 2024 | 62.66% |
April 25, 2024 | 65.36% |
April 24, 2024 | 51.23% |
April 23, 2024 | 40.70% |
April 22, 2024 | 45.93% |
April 19, 2024 | 39.77% |
April 18, 2024 | 44.77% |
April 17, 2024 | 60.49% |
April 16, 2024 | 48.12% |
April 15, 2024 | 49.38% |
Date | Value |
---|---|
April 12, 2024 | 42.94% |
April 11, 2024 | 56.79% |
April 10, 2024 | 68.79% |
April 09, 2024 | 67.28% |
April 08, 2024 | 71.60% |
April 05, 2024 | 92.26% |
April 04, 2024 | 80.98% |
April 03, 2024 | 75.00% |
April 02, 2024 | 78.43% |
April 01, 2024 | 78.43% |
March 28, 2024 | 82.24% |
March 27, 2024 | 70.42% |
March 26, 2024 | 71.07% |
March 25, 2024 | 68.55% |
March 22, 2024 | 71.88% |
March 21, 2024 | 56.40% |
March 20, 2024 | 58.29% |
March 19, 2024 | 56.67% |
March 18, 2024 | 58.33% |
March 15, 2024 | 70.22% |
March 14, 2024 | 60.44% |
March 13, 2024 | 66.67% |
March 12, 2024 | 71.01% |
March 11, 2024 | 72.19% |
March 08, 2024 | 67.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.30%
Minimum
Oct 11 2019
343.7%
Maximum
Mar 23 2021
13.55%
Average
-3.38%
Median
Oct 28 2021
1 Year Total Returns (Daily) Benchmarks
NextCure Inc | -4.57% |
NovaBay Pharmaceuticals Inc | -83.53% |
Palatin Technologies Inc | -18.03% |
iBio Inc | -89.71% |
Theriva Biologics Inc | -47.04% |